Scientists at the University of Cambridge have created a test that could predict if a cancer patient is sensitive or resistant to different types of chemotherapy. This could help thousands of patients ...

CNS Pharmaceuticals (NASDAQ: CNSP) announced the release of a Virtual Investor KOL Connect segment featuring Dr. Erin Dunbar, Director of Neuro-Oncol ...

Cancer Research UK-funded scientists at the University of Cambridge create a test to predict resistance to chemotherapy. The test uses changes to cancer DNA at diagnosis to predict which patients will ...

Chemotherapy seeks to destroy tumor cells and has been a standard treatment for cancer for decades. However, it doesn't ...

Tens of thousands of cancer patients going through gruelling chemotherapy could have DNA test to predict which form of the ...